LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
LONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal...